Zhanguo Li

Title: Innovations and Contributions of Inventor Zhanguo Li

Introduction

Zhanguo Li is a notable inventor based in Beijing, China. He has made significant contributions to the fields of biomedical research and engineering. With a total of three patents to his name, his work focuses on innovative methods and apparatuses that address critical health and engineering challenges.

Latest Patents

Zhanguo Li's latest patents include a method for predicting and monitoring the efficacy of low-dose IL-2 and hydroxychloroquine therapy in autoimmune diseases. This method aims to treat systemic lupus erythematosus (SLE) and primary Sjögren's Syndrome (pSS) by administering a therapeutically effective low-dose amount of interleukin-2 and hydroxychloroquine. The combination of these treatments has shown promise in inhibiting or treating these autoimmune conditions. Another significant patent involves a method and apparatus for determining the separation efficiency of a cyclone separator. This invention provides a systematic approach to analyze solid particles separated by the cyclone separator, allowing for accurate calculations of separation efficiency while minimizing operational difficulties.

Career Highlights

Throughout his career, Zhanguo Li has worked with reputable organizations such as KSL Biomedical Inc. and North China Electric Power Research Institute Co., Ltd. His experience in these companies has contributed to his expertise in developing innovative solutions in his field.

Collaborations

Zhanguo Li has collaborated with notable colleagues, including Jing He and Jinjing Li. These partnerships have likely enhanced his research and development efforts, leading to impactful inventions.

Conclusion

Zhanguo Li's contributions to innovation in biomedical research and engineering are commendable. His patents reflect a commitment to addressing significant health issues and improving engineering processes. His work continues to inspire advancements in these critical fields.